Filamin a mediates HGF/c-MET signaling in tumor cell migration

International Journal of Cancer

Volumn 128, Issue 4, 2011, Pages 839-846

  Zhou, Alex Xianghua ^a,b   Toylu, Asli ^a,c   Nallapalli, Rajesh K ^a   Nilsson, Gisela ^a   Atabey, Neşe ^c   Heldin, Carl Henrik ^d   Borén, Jan ^b   Bergo, Martin O ^b   Akyürek, Levent M ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

fibroblasts; invasion; melanoma cells; migration

Indexed keywords

FILAMIN A; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMAD2 PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; CONTRACTILE PROTEINS; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; MICE; MICROFILAMENT PROTEINS; NEOPLASMS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 78650615598     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25417     Document Type: Article

References (30)

1. Comoglio PM, Giordano S, Trusolino L,. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008; 7: 504-16.
2. Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM,. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 2001; 153: 1023-34.
3. Knudsen BS, Vande Woude G,. Showering c-MET-dependent cancers with drugs. Curr Opin Genet Dev 2008; 18: 87-96.
4. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF,. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-25.
5. Boccaccio C, Comoglio PM,. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006; 6: 637-45.
6. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF,. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 1994; 91: 4731-5.
7. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G,. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 1997; 94: 701-6.
8. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, Shapiro SS,. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2001; 2: 138-45.
9. Zhou X, Boren J, Akyürek LM,. Filamins in cardiovascular development. Trends Cardiovasc Med 2007; 17: 222-9.
10. Guedj N, Zhan Q, Perigny M, Rautou PE, Degos F, Belghiti J, Farges O, Bedossa P, Paradis V,. Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol 2009; 51: 93-101.
11. Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA, Singh N, Tartakoff A, Abbott DW, Xin W, Sy MS,. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest 2009; 119: 2725-36.
12. Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Özdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, Oldfield EH, Tong Y, et al. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci 2009; 100: 1748-56.
13. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, Arenberg DA, Reddy RC, Akulapalli S, Thannickal VJ, Standiford TJ, Andrews PC, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 2006; 5: 1143-54.
14. Ravid D, Chuderland D, Landsman L, Lavie Y, Reich R, Liscovitch M,. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Exp Cell Res 2008; 314: 2762-73.
15. Kamochi N, Nakashima M, Aoki S, Uchihashi K, Sugihara H, Toda S, Kudo S,. Irradiated fibroblast-induced bystander effects on invasive growth of squamous cell carcinoma under cancer-stromal cell interaction. Cancer Sci 2008; 99: 2417-27.
16. McDonough WS, Tran NL, Berens ME,. Regulation of glioma cell migration by serine-phosphorylated P311. Neoplasia 2005; 7: 862-72.
17. Cunningham CC, Gorlin JB, Kwiatkowski DJ, Hartwig JH, Janmey PA, Byers HR, Stossel TP,. Actin-binding protein requirement for cortical stability and efficient locomotion. Science 1992; 255: 325-7.
18. Hart AW, Morgan JE, Schneider J, West K, McKie L, Bhattacharya S, Jackson IJ, Cross SH,. Cardiac malformations and midline skeletal defects in mice lacking filamin A. Hum Mol Genet 2006; 15: 2457-67.
19. Björndahl M, Cao R, Eriksson A, Cao Y,. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion. Circ Res 2004; 94: 1443-50.
20. Zhang X, Yang J, Li Y, Liu Y,. Both Sp1 and Smad participate in mediating TGF-β1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol 2005; 288: F16-26.
21. Sasaki A, Masuda Y, Ohta Y, Ikeda K, Watanabe K,. Filamin associates with Smads and regulates transforming growth factor-β signaling. J Biol Chem 2001; 276: 17871-7.
22. Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, Merlino G,. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 1998; 58: 5157-67.
23. Gentile A, Trusolino L, Comoglio PM,. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008; 27: 85-94.
24. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP,. The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 1999; 96: 2122-8.
25. Cerezo A, Guadamillas MC, Goetz JG, Sanchez-Perales S, Klein E, Assoian RK, Del Pozo MA,. The absence of caveolin-1 increases proliferation and achorage-independent growth by a Rac-dependent, Erk-independent mechanism. Mol Cell Biol 2009; 29: 5046-59.
26. Presnell SC, Stolz DB, Mars WM, Jo M, Michalopoulos GK, Strom SC,. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-α in rat liver epithelial cells. Mol Carcinog 1997; 18: 244-55.
27. Cao R, Björndahl MA, Gallego MI, Chen S, Religa P, Hansen AJ, Cao Y,. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 2006; 107: 3531-6.
28. Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F, Kwiztkowski DJ, Walsh CA,. Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci USA 2006; 103: 19836-41.
29. Del Valle-Perez B, Martinez VG, Lacasa-Salavert C, Figueras A, Shapiro SS, Takafuta T, Casanovas O, Capella G, Ventura F, Vinals F,. Filamin B plays a key role in VEGF-induced endothelial cell motility through its interaction with Rac-1 and Vav-2. J Biol Chem 2010; 285: 10748-60.
30. Feng Y, Walsh CA,. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 2004; 6: 1034-8.